Renin-angiotensin-system-acting agents - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 all comers

	COVID 19 all comers
Renin-angiotensin-system-acting agents
angiotensin receptor blockers (ARBs)
losartan	University of Minnesota

8 studies excluded by filtering options 1

5092	Yang, 2020	1	13	3		not a RCT	high risk of bias
5228	Bean, 2020	1	19	3		not a RCT	high risk of bias
5295	Zhang, 2020	1	13	3		not a RCT	high risk of bias
5331	Li, 2020	1	13	4		not a RCT	high risk of bias
5332	Meng, 2020	1	13	4		not a RCT	high risk of bias
5345	Yan et al., 2020	1	20	4		not a RCT	high risk of bias
6139	Dublin, 2020	0	12	0	selection pending
6139	Dublin, 2020	0	12	0	selection pending